Clinical Outcomes After Stereotactic Microwave Ablation for Colorectal Liver Metastases: Single-Center Experience
British Journal of Surgery · 03.06.2026 · 113 (Supplement_5)
DOI: 10.1093/bjs/znag055.028 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 03.06.2026. Verfasst von A Fiore und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Colorectal cancer (CRC) is the third most common cancer worldwide, with 25-30% of patients develop liver metastases (CRLM). Although hepatic resection remains the preferred treatment, recurrence occurs in 50-70% of cases. Thermal ablation is increasingly used for unresectable and deep seeded metastases < 3cm. Stereotactic microwave ablation (SMWA) has emerged as a highly precise ablation technique offering planning, navigation and validation during the intervention and the possibility to treat invisible lesions by MRI fusion.
Aims
A comprehensive analysis of patients undergoing SMWA for CRLM aims to identify factors influencing recurrence, oncological outcome and overall survival.
Methods
Retrospective analysis of a cohort of 89 patients treated at the Bern University Hospital for CRLM with SMWA between 2014 and 2024 Results A total of 89 patients underwent SMWA, with a mean age of 65.5 years. A total of 56 (62.9%) patients presented with synchronous CRLM at the time of SMWA. A total of 172 lesions in 105 interventions were treated. Post-interventional complications occurred in 5 (5.6%) patients. The overall survival, from the first treatment to last Follow-up was 35.6 (±22) months, disease progression was seen in 65 (73%) patients, whereas local recurrence after SMWA was observed in 30 (17.4%) patients, with a mean recurrence-free survival of 7.8 (±5.2) months. Fifteen (50%) of patients with local recurrence were treated with subsequent surgical resection. The influence of the ablation margin using an ablation validation software and a potential correlation with tumor size and anatomic location will now be assessed in order to identify risk factors for recurrence.
Conclusion
In this cohort, post-interventional complications were infrequent, and both overall survival and local recurrence rates were consistent with those reported in the literature following ablation or resection. SMWA for CRLM represents a safe and effective local treatment option.
Zitieren
APA
Fiore, A., Gloor, S., Beldi, G., Candinas, D., Komarek, A., & Anja, L. (2026). Clinical Outcomes After Stereotactic Microwave Ablation for Colorectal Liver Metastases: Single-Center Experience. British Journal of Surgery, 113(Supplement_5). https://doi.org/10.1093/bjs/znag055.028
Vancouver
Fiore A, Gloor S, Beldi G, Candinas D, Komarek A, Anja L. Clinical Outcomes After Stereotactic Microwave Ablation for Colorectal Liver Metastases: Single-Center Experience. British Journal of Surgery. 2026;113(Supplement_5). doi:10.1093/bjs/znag055.028
BibTeX
@article{Fiore2026,
author = {Fiore, A and Gloor, S and Beldi, G and Candinas, D and Komarek, A and Anja, L},
title = {Clinical Outcomes After Stereotactic Microwave Ablation for Colorectal Liver Metastases: Single-Center Experience},
journal = {British Journal of Surgery},
year = {2026},
volume = {113},
number = {Supplement_5},
doi = {10.1093/bjs/znag055.028}
}
EUVIMED